In the trials of these drug classes, tirzepatide (the SURMOUNT program) produced average weight loss roughly in the 15% to 21% range across doses at about 72 weeks, while semaglutide (the STEP program) produced around 15% at about 68 weeks
A dusty desk does not
Efficacy analyses were performed on two sets: the full analysis set, defined as all unique randomized patients grouped according to the treatment assigned at randomization, thereby following the intent-to-treat principle, and an on-treatment analysis, defined as all exposed patients while they were receiving treatment (that is, had received at least one dose in the previous 35 d), grouped according to the treatment that they received
Despite the global uncertainties, LifeWave quickly gained traction, fuelled by growing interest in non-invasive, health-enhancing alternatives
Berryhill S, Morton CJ, Dean A, Berryhill A, Provencio-Dean N, Patel SI, Estep L, Combs D, Mashaqi S, Gerald LB, Krishnan JA, Parthasarathy S